America's Business-to-Business Journal for Industry
   Subscribe      Advertise       Submit News       Feedback       Jobs   
Virginia News
Similar Articles:
Massey Energy Announces Agreement to Acquire Cumberland Resources Corporation
Kentucky's Beacon Enterprise Solutions to Acquire Belgium Based NetConnect BVBA
MFRI Announces Joint Acquisition of Pipe Coating and Insulating Facility in Alberta, Canada

Virginia-based Commonwealth Biotechnologies Inks Deal to Acquire Foreign Pharmaceutical Supplier

Shanghai-based GL Biochem said to be the largest provider of research-grade peptide products and peptide reagents globally



(Richmond, Virginia) - Commonwealth Biotechnologies Inc. (NASDAQ Capital Market:CBTE) says it has signed a deal to acquire GL Biochem Ltd., a privately owned Shanghai-based chemical company and the largest supplier of research-grade peptide products and peptide reagents globally.

The transaction will involve issuing 6.56 million fully paid ordinary CBI shares to the shareholders of GL Biochem, representing 51% of CBI's outstanding share capital. As part of the transaction, GL Biochem will grant CBI an option to purchase all the issued capital of three related businesses, namely GL Biochem (Danyang) Ltd, GL Peptide (Shanghai) Ltd and GL Peptide (Binhai) Ltd within twelve months of the closing of the transaction.

The purchase price of the option will range between 8.14 million shares and 18.64 million CBI shares, based on the coming 2008 audited after-tax profit results of GL Biochem and its associated companies. This deal is subject to the completion of audits of GL Biochem and the approval of Commonwealth Biotechnologies shareholders and lenders.

Over the past 5 years, GL Biochem and related businesses have seen annual revenue growth of more than 40%. Based on an independent report, they reported 2008 revenues of over $13 million and net income after tax of about $2 million.

“Peptides make up only a small proportion of the pharmaceutical products on the market today but represent one of the fastest growing classes of new drugs because of their high activity and specificity, low toxicity and high degree of potential chemical diversity,” Dr. Paul D'Sylva, Director of CBI and Chairman of Mimotopes.

CBI offers research and development products and services to the global life sciences industry. CBI now operates through: CBI Services, a discovery phase contract research organization; Fairfax Identity Laboratories, a DNA reference business; Mimotopes Pty Ltd, Melbourne, Australia, a peptide and discovery chemistry business; and Venturepharm (Asia), a contract research consortium specializing in drug discovery and development, process scale-up, formulation development, cGMP manufacturing and clinical trial management.

For more information about the company visit http://www.cbi-biotech.com/commonwealthbio/

For a complete version of the BUSINESS WIRE press release: http://www.businesswire.com/news/home/20090608005951/en


All comment postings require your name and email address for user verification only. Your email address will not be used or distributed for any other purpose.
No advertising is permitted and will result in the post being deleted and/or banning. Please click "REPORT" to report any inappropriate posts.
blog comments powered by Disqus


Permission to Reproduce:
Unless otherwise stated, the copyright and similar rights to all material published on this website are owned by The Manufacturers Group Inc. DBA Manufacturing & Technology eJournal. Reproduction of any article in print, electronic or any other form must acknowledge Manufacturing & Technology eJournal as the Source and include a link to http://www.mfrtech.com


Latest Ohio News:
ARRA Brownfield Revolving Loan Fund Opportunity for Ohio

O-I Enters Argentinean Market with Acquisition of Glassmaker Cristalerias Rosario

Reynolds Machinery Adds Samsung Line of Turning Centers and Machining Centers


Latest Indiana News:
Novae Corporation Manufacturer to Establish New Production Facility

Technology Firm, BlueLock, to Expand In Indianapolis

Rolls-Royce Awarded $75 Million MissionCare Contract for V-22 Osprey Engine Support


Latest Kentucky News:
$3.9 Million Expansion at Caldwell Tanks in Louisville

Masonite Completes Acquisition of LEDCO

Howa Textile Industry Co., Auto Supplier, To Move Richmond, Indiana Operations to Kentucky

Kentuckiana Curb Expanding in Louisville

Signature HealthCARE to Move National Headquarters to Louisville, Kentucky


Latest Michigan News:
More Than 7,180 New Jobs Planned for Michigan

KMT Robotic Solutions Extends Relationship with FANUC Robotics America

Dow Announces Sale of Styron Division to Bain Capital for $1.63 Billion


Other News:
How to Lower Your Welding Costs

What Role if Any Do Unions Play in Your Business? We Would Like To Hear From You

The Engineering Pyramid: Increasing the Speed of Innovation

Massey Energy Announces Agreement to Acquire Cumberland Resources Corporation

Technical Services for RFID, Networking, and Sensor Projects from Balluff

Eastman to Acquire Genovique Specialties, a Producer of Non-Phthalate Plasticizers

The Critical Realities Driving PLM Initiatives

10 District Polls Showing Voters Opposed to Current Health Care Proposal

Simplify Inventory Receiving, Shipping, and Activity Reporting with Web-based Inventory Management

And Don't Miss
Our Most Recent Cover Stories
Letters, Comments, and Forums
National News
Other States
White Papers
Return to our Home Page